Thus, calystegines would improve the functions of ASCs cells through their ability to restore insulin signalling, confirming their utility as antidiabetic and antihyperglycaemic agents, which has even been proven in an in vivo model of STZ-induced diabetes in albino mice [44]. The gene discussed is INS; the disease is diabetes mellitus.